Clinical trial
Autologous Hematopoietic Stem Cell Transplantation for Refractory Crohn's Disease
NCT04224558 is registered in ClinicalTrials.gov with Cedars-Sinai Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Autologous Hematopoietic Stem Cell Transplantation for Refractory Crohn's Disease
- Lead sponsor
- Cedars-Sinai Medical Center
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- November 15, 2019
- Completion date
- September 30, 2027
- Enrollment
- 15 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.